DES Converted    Prevention of lesion recurrence in chronic total coronary occlusions by paclitaxel-eluting stents J Am Coll Cardiol (2004);44:2301-6 G. S. Werner, et al. The paclitaxel (TAXUS)-eluting stent: a review of its use in the management of de novo coronary artery lesions Am J Cardiovasc Drugs (2004);4:257-68 J. Waugh and A. J. Wagstaff Late coronary thrombosis secondary to a sirolimus-eluting stent Circulation (2004);110:e309; author reply e309 B. H. Walpoth and O. M. Hess Localized hypersensitivity and late coronary thrombosis secondary to a sirolimus-eluting stent: should we be cautious? Circulation (2004);109:701-5 R. Virmani, et al. Chronic arterial responses to polymer-controlled paclitaxel-eluting stents: comparison with bare metal stents by serial intravascular ultrasound analyses: data from the randomized TAXUS-II trial Circulation (2004);109:196-200 K. Tanabe, et al. Incomplete stent apposition after implantation of paclitaxel-eluting stents or bare metal stents: insights from the randomized TAXUS II trial Circulation (2005);111:900-5 K. Tanabe, et al. Restenosis rates following bifurcation stenting with sirolimus-eluting stents for de novo narrowings Am J Cardiol (2004);94:115-8 K. Tanabe, et al. Nonuniform strut distribution correlates with more neointimal hyperplasia after sirolimus-eluting stent implantation Circulation (2004);110:3430-4 H. Takebayashi, et al. A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease N Engl J Med (2004);350:221-31 G. W. Stone, et al. One-year clinical results with the slow-release, polymer-based, paclitaxel-eluting TAXUS stent: the TAXUS-IV trial Circulation (2004);109:1942-7 G. W. Stone, et al. Marked malapposition and aneurysm formation after sirolimus-eluting coronary stent implantation Circulation (2004);110:e47-8 E. Stabile, et al. Impact of final stent dimensions on long-term results following sirolimus-eluting stent implantation: serial intravascular ultrasound analysis from the sirius trial J Am Coll Cardiol (2004);43:1959-63 S. Sonoda, et al. Actinomycin-eluting stent for coronary revascularization: a randomized feasibility and safety study: the ACTION trial J Am Coll Cardiol (2004);44:1363-7 P. W. Serruys, et al. Sirolimus eluting stent implantation for patients with multivessel disease: rationale for the Arterial Revascularisation Therapies Study part II (ARTS II) Heart (2004);90:995-8 P. W. Serruys, et al. Vascular responses at proximal and distal edges of paclitaxel-eluting stents: serial intravascular ultrasound analysis from the TAXUS II trial Circulation (2004);109:627-33 P. W. Serruys, et al. Are drug-eluting stents a panacea for patients with coronary heart disease? Lancet (2004);364:558-9 J. Schofer and M. Schluter Direct stenting of native de novo coronary artery lesions with the sirolimus-eluting stent: a post hoc subanalysis of the pooled E- and C-SIRIUS trials J Am Coll Cardiol (2005);45:10-3 M. Schluter, et al. Diabetes is still a risk factor for restenosis after drug-eluting stent in coronary arteries Diabetes Care (2004);27:1840-1 A. J. Scheen and F. Warzee The Canadian study of the sirolimus-eluting stent in the treatment of patients with long de novo lesions in small native coronary arteries (C-SIRIUS) J Am Coll Cardiol (2004);43:1110-5 E. Schampaert, et al. Treatment of left anterior descending coronary artery disease with sirolimus-eluting stents Circulation (2004);110:374-9 N. Sawhney, et al. Clinical and angiographic outcomes after overdilatation of undersized sirolimus-eluting stents with largely oversized balloons: an observational study Catheter Cardiovasc Interv (2004);61:455-60 F. Saia, et al. Routine sirolimus eluting stent implantation for unselected in-stent restenosis: insights from the rapamycin eluting stent evaluated at Rotterdam Cardiology Hospital (RESEARCH) registry Heart (2004);90:1183-8 F. Saia, et al. Bivalirudin versus heparin as an antithrombotic agent in patients treated with a sirolimus-eluting stent Am J Cardiol (2004);94:1047-50 S. W. Rha, et al. Incidence of thrombotic stent occlusion during the first three months after sirolimus-eluting stent implantation in 500 consecutive patients Am J Cardiol (2004);93:1271-5 E. Regar, et al. Quantitative assessment of angiographic restenosis after sirolimus-eluting stent implantation in native coronary arteries Circulation (2004);110:3773-80 J. J. Popma, et al. Choosing a drug-eluting stent: a comparison between CYPHER and TAXUS Rev Cardiovasc Med (2005);6 Suppl 1:S13-21 E. C. Perin Sirolimus-eluting stent implantation for unprotected left main coronary artery stenosis: comparison with bare metal stent implantation J Am Coll Cardiol (2005);45:351-6 S. J. Park, et al. Rapamycin-eluting stents for the treatment of bifurcated coronary lesions: a randomized comparison of a simple versus complex strategy Am Heart J (2004);148:857-64 M. Pan, et al. Drug-eluting stents for coronary bifurcations: insights into the crush technique Catheter Cardiovasc Interv (2004);63:332-6 J. A. Ormiston, et al. Treatment of multivessel coronary artery disease with sirolimus-eluting stent implantation: immediate and mid-term results J Am Coll Cardiol (2004);43:1154-60 D. Orlic, et al. Impact of sirolimus-eluting stent on the outcome of patients with chronic total occlusions Am J Cardiol (2005);95:161-6 S. Nakamura, et al. Intravascular ultrasound study of effects of overlapping sirolimus-eluting stents Am J Cardiol (2004);93:470-3 J. S. Munoz, et al. Impact of sirolimus-eluting stents on outcome in diabetic patients: a SIRIUS (SIRolImUS-coated Bx Velocity balloon-expandable stent in the treatment of patients with de novo coronary artery lesions) substudy Circulation (2004);109:2273-8 I. Moussa, et al. The use of drug eluting stents in single and multivessel disease: results from a single centre experience Heart (2004);90:990-4 G. W. Mikhail, et al. Post-sirolimus-eluting stent restenosis treated with repeat percutaneous intervention: late angiographic and clinical outcomes Circulation (2004);109:2500-2 P. A. Lemos, et al. Unrestricted utilization of sirolimus-eluting stents compared with conventional bare stent implantation in the "real world": the Rapamycin-Eluting Stent Evaluated At Rotterdam Cardiology Hospital (RESEARCH) registry Circulation (2004);109:190-5 P. A. Lemos, et al. Short- and long-term clinical benefit of sirolimus-eluting stents compared to conventional bare stents for patients with acute myocardial infarction J Am Coll Cardiol (2004);43:704-8 P. A. Lemos, et al. Comparison of late luminal loss response pattern after sirolimus-eluting stent implantation or conventional stenting Circulation (2004);110:3199-205 P. A. Lemos, et al. Clinical, angiographic, and procedural predictors of angiographic restenosis after sirolimus-eluting stent implantation in complex patients: an evaluation from the Rapamycin-Eluting Stent Evaluated At Rotterdam Cardiology Hospital (RESEARCH) study Circulation (2004);109:1366-70 P. A. Lemos, et al. Treatment of very small vessels with 2.25-mm diameter sirolimus-eluting stents (from the RESEARCH registry) Am J Cardiol (2004);93:633-6 P. A. Lemos, et al. Non-polymer-based paclitaxel-coated coronary stents for the treatment of patients with de novo coronary lesions: angiographic follow-up of the DELIVER clinical trial Circulation (2004);109:1948-54 A. J. Lansky, et al. Complex coronary intervention in the drug-eluting stent era. Introduction Rev Cardiovasc Med (2005);6 Suppl 1:S1-2 D. J. Kereiakes Sirolimus-eluting stent or paclitaxel-eluting stent vs balloon angioplasty for prevention of recurrences in patients with coronary in-stent restenosis: a randomized controlled trial Jama (2005);293:165-71 A. Kastrati, et al. Comparison of neointimal formation in polymer-free paclitaxel stents versus stainless stents (from the ASPECT and ELUTES randomized clinical trials) Am J Cardiol (2004);94:199-201 G. L. Kaluza, et al. Stent thrombosis after successful sirolimus-eluting stent implantation Circulation (2004);109:1930-2 A. Jeremias, et al. Sirolimus- and paclitaxel-eluting stents in comparison with balloon angioplasty for treatment of in-stent restenosis Catheter Cardiovasc Interv (2005);64:28-34 E. Iofina, et al. Effectiveness of sirolimus-eluting stent implantation for treatment of in-stent restenosis after brachytherapy failure Am J Cardiol (2004);94:351-4 I. Iakovou, et al. Clinical and angiographic outcome after sirolimus-eluting stent implantation in aorto-ostial lesions J Am Coll Cardiol (2004);44:967-71 I. Iakovou, et al. Significant reduction in restenosis after the use of sirolimus-eluting stents in the treatment of chronic total occlusions J Am Coll Cardiol (2004);43:1954-8 A. Hoye, et al. Effectiveness of the sirolimus-eluting stent in the treatment of saphenous vein graft disease J Invasive Cardiol (2004);16:230-3 A. Hoye, et al. Effectiveness of sirolimus-Eluting stent implantation for coronary narrowings <50% in diameter Am J Cardiol (2004);94:112-4 A. Hoye, et al. Effect of abciximab-coated stent on in-stent intimal hyperplasia in human coronary arteries Am J Cardiol (2004);94:1050-4 Y. J. Hong, et al. Analysis of 1-year clinical outcomes in the SIRIUS trial: a randomized trial of a sirolimus-eluting stent versus a standard stent in patients at high risk for coronary restenosis Circulation (2004);109:634-40 D. R. Holmes, Jr., et al. Evaluation of a high-dose dexamethasone-eluting stent Am J Cardiol (2004);94:193-5 R. Hoffmann, et al. Drug-eluting stent task force: final report and recommendations of the working committees on cost-effectiveness/economics, access to care, and medicolegal issues Catheter Cardiovasc Interv (2004);62:1-17 J. M. Hodgson, et al. Randomized, double-blind, placebo-controlled trial of oral sirolimus for restenosis prevention in patients with in-stent restenosis: the Oral Sirolimus to Inhibit Recurrent In-stent Stenosis (OSIRIS) trial Circulation (2004);110:790-5 J. Hausleiter, et al. Six- and twelve-month results from first human experience using everolimus-eluting stents with bioabsorbable polymer Circulation (2004);109:2168-71 E. Grube, et al. High-dose 7-hexanoyltaxol-eluting stent with polymer sleeves for coronary revascularization: one-year results from the SCORE randomized trial J Am Coll Cardiol (2004);44:1368-72 E. Grube, et al. Rapamycin analogs for stent-based local drug delivery. Everolimus- and tacrolimus-eluting stents Herz (2004);29:162-6 E. Grube and L. Buellesfeld Vascular brachytherapy versus sirolimus eluting stents for the treatment of in-stent restenosis: a prospective registry Heart (2004);90:1491-2 J. J. Goy, et al. Inhibition of restenosis with a paclitaxel-eluting, polymer-free coronary stent: the European evaLUation of pacliTaxel Eluting Stent (ELUTES) trial Circulation (2004);109:487-93 A. Gershlick, et al. Contribution of stent underexpansion to recurrence after sirolimus-eluting stent implantation for in-stent restenosis Circulation (2004);109:1085-8 K. Fujii, et al. One-year clinical results with the slow-release, polymer-based, paclitaxel-eluting TAXUS stent in patients with diabetes mellitus Circulation (2004);110:e318-9; author reply e318-9 A. V. Finn and H. K. Gold Relation of intimal hyperplasia thickness to stent size in paclitaxel-coated stents Am J Cardiol (2004);94:196-8 E. Escolar, et al. Very long sirolimus-eluting stent implantation for de novo coronary lesions Am J Cardiol (2004);93:826-9 M. Degertekin, et al. Rapamycin-eluting stents for the treatment of unprotected left main coronary disease Am Heart J (2004);148:481-5 J. S. de Lezo, et al. Angiographic results of the first human experience with everolimus-eluting stents for the treatment of coronary lesions (the FUTURE I trial) Am J Cardiol (2005);95:113-6 R. A. Costa, et al. Randomized study to evaluate sirolimus-eluting stents implanted at coronary bifurcation lesions Circulation (2004);109:1244-9 A. Colombo, et al. Single-digit target vessel revascularization in multivessel coronary interventions with sirolimus-eluting stents: goodbye to coronary bypass grafting Catheter Cardiovasc Interv (2004);63:61-2 A. Colombo Cost-effectiveness of sirolimus-eluting stents for treatment of complex coronary stenoses: results from the Sirolimus-Eluting Balloon Expandable Stent in the Treatment of Patients With De Novo Native Coronary Artery Lesions (SIRIUS) trial Circulation (2004);110:508-14 D. J. Cohen, et al. Early and mid-term results of drug-eluting stent implantation in unprotected left main Circulation (2005);111:791-5 A. Chieffo, et al. Intraprocedural stent thrombosis during implantation of sirolimus-eluting stents Circulation (2004);109:2732-6 A. Chieffo, et al. ABT-578-eluting stents. The promising successor of sirolimus- and paclitaxel-eluting stent concepts? Herz (2004);29:167-70 L. Buellesfeld and E. Grube Usefulness of high-pressure post-dilatation to optimize deployment of drug-eluting stents for the treatment of diffuse in-stent coronary restenosis Am J Cardiol (2004);94:922-5 D. J. Blackman, et al. A hierarchical Bayesian meta-analysis of randomised clinical trials of drug-eluting stents Lancet (2004);364:583-91 M. N. Babapulle, et al. Sirolimus-eluting vs uncoated stents for prevention of restenosis in small coronary arteries: a randomized trial Jama (2004);292:2727-34 D. Ardissino, et al. Elective sirolimus-eluting stent implantation for left main coronary artery disease: six-month angiographic follow-up and 1-year clinical outcome Catheter Cardiovasc Interv (2004);62:292-6; discussion 297 C. A. Arampatzis, et al. Elective sirolimus-eluting stent implantation for multivessel disease involving significant LAD stenosis: one-year clinical outcomes of 99 consecutive patients--the Rotterdam experience Catheter Cardiovasc Interv (2004);63:57-60 C. A. Arampatzis, et al. Comparison of clinical and angiographic outcome of sirolimus-eluting stent implantation versus cutting balloon angioplasty for coronary in-stent restenosis Am J Cardiol (2004);94:1297-300 F. Airoldi, et al. Paclitaxel prevented restenosis in a totally occluded small vessel with in-stent restenosis: a 9-month angiographic follow-up Catheter Cardiovasc Interv (2004);61:392-5 A. F. Aboufares, et al. Sirolimus-eluting stents inhibit neointimal hyperplasia in diabetic patients. Insights from the RAVEL Trial Eur Heart J (2004);25:107-12 A. Abizaid, et al. First human experience with the 17-beta-estradiol-eluting stent: the Estrogen And Stents To Eliminate Restenosis (EASTER) trial J Am Coll Cardiol (2004);43:1118-21 A. Abizaid, et al.